$8.69+0.30 (+3.58%)
Teladoc Health, Inc.
Teladoc Health, Inc. in the Healthcare sector is trading at $8.88 with a market capitalization of $1.3B. Wall Street consensus targets $7.40 (20 analysts), implying a -16.7% move over the next 12 months. The stock is currently near its 52-week high of $9.77, remaining 30.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $613.85Mβ | $642.27Mβ | $626.44Mβ | $631.90Mβ | $629.37M |
| Gross Profit | $416.32Mβ | $445.22Mβ | $439.26Mβ | $441.36Mβ | $432.54M |
| Operating Income | -$48.73Mβ | -$26.97Mβ | -$35.46Mβ | -$46.03Mβ | -$54.94M |
| Net Income | -$63.84Mβ | -$25.14Mβ | -$49.51Mβ | -$32.66Mβ | -$93.01M |
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical se...
A number of stocks jumped in the afternoon session after signs of renewed diplomatic talks between the U.S. and Iran boosted investor sentiment.
Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Teladoc (TDOC) concluded the recent trading session at $7.81, signifying a +1.56% move from its prior day's close.
With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.
Teladoc (TDOC) reached $7.57 at the closing of the latest trading day, reflecting a +1.47% change compared to its last close.